Skip to main content

Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.

Publication ,  Conference
McDonald, KL; Khasraw, M; Ashley, DM
Published in: Journal of Clinical Oncology
May 20, 2015

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

2071 / 2071

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McDonald, K. L., Khasraw, M., & Ashley, D. M. (2015). Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy. In Journal of Clinical Oncology (Vol. 33, pp. 2071–2071). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.2071
McDonald, Kerrie Leanne, Mustafa Khasraw, and David M. Ashley. “Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.” In Journal of Clinical Oncology, 33:2071–2071. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.2071.
McDonald KL, Khasraw M, Ashley DM. Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 2071–2071.
McDonald, Kerrie Leanne, et al. “Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 2071–2071. Crossref, doi:10.1200/jco.2015.33.15_suppl.2071.
McDonald KL, Khasraw M, Ashley DM. Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 2071–2071.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

2071 / 2071

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences